Enzymatic Resolution of Diltiazem Intermediate by Serratia and Its Industrial Application
Enzymatic Resolution of Diltiazem Intermediate by Serratia and Its Industrial Application
Enzymatic Resolution of Diltiazem Intermediate by Serratia and Its Industrial Application
141–149
www.elsevier.comrlocatermolcatb
Abstract
A lipase from Serratia marcescens was selected as an asymmetric hydrolytic enzyme for trans-3-Ž4-
methoxyphenyl.glycidic acid methyl ester wŽ".-MPGMx, a key intermediate in the synthesis of diltiazem hydrochloride that
is useful as a coronary vasodilator. This lipase has high enantioselectivity Ž E s 135. and was applied to the industrial
production of the optically active intermediate of diltiazem using two-phase reaction system of organic solvent–water.
Introduction of enzymatic reaction into the chemical synthetic route of diltiazem reduces the number of processes from nine
to five. Analyses of the secretion mechanism of the lipase from S. marcescens cell membrane revealed that lipase ŽLipA.,
metalloprotease ŽPrtA., cell surface protein ŽSlaA. and flagellin are secreted via ABC-transporter, which is a common
secreting mechanism in Gram-negative bacteria other than N-terminal signal peptide-dependent secreting mechanism.
Molecular cloning of both the lipA gene, which codes the lipase protein, and lipBCD genes, which code the secretion device
proteins, enable the production of the lipase by the self-cloning strain 140-fold as compared to the wild type strain.
Immobilization of the lipase on a hollow fiber type membrane reactor contributes to the repeated use of enzyme and to
efficient separation of the reaction product. Thus, enzymatic reaction and product separation are achieved simultaneously.
q 2000 Elsevier Science B.V. All rights reserved.
Keywords: Enzymatic resolution; Optically active compound; Lipase; Secretion; Hollow fiber type membrane reactor; Diltiazem
1381-1177r00r$ - see front matter q 2000 Elsevier Science B.V. All rights reserved.
PII: S 1 3 8 1 - 1 1 7 7 Ž 0 0 . 0 0 1 2 2 - 3
142 T. Shibatani et al.r Journal of Molecular Catalysis B: Enzymatic 10 (2000) 141–149
Diltiazem is a representative calcium channel itself was very efficient, a simpler and more
blocker and is used throughout the world to economical process was required to reduce the
treat angina pectoris, hypertension and several production cost of diltiazem.
other circulatory disorders w1,2x. We developed recently an enzymatic prepara-
Diltiazem has two asymmetric carbons in its tion of an optically active intermediate, methyl
chemical structure. Among the four possible Ž y . - Ž 2 R ,3S . -3- Ž 4-methoxyphenyl . glycidate
stereoisomers of diltiazem, only the Žq.- wcompound 3, Fig. 1x, and we utilized the enzy-
Ž2 S,3S .-isomer exhibits potent coronary vasodi- matic resolution process in industrial production
lating activity. Therefore, diltiazem has been of diltiazem w3–5x. In our studies, we found a
developed and marketed as a single isomer. new lipase from Serratia marcescens, which
In order to obtain the desired optical isomer, has a high enantioselectivity, E s 135, for the
various methods have been developed and the compound Žq.-3 wFig. 1x and we demonstrated
conventional chemical synthetic route is illus- that the lipase from S. marcescens is different
trated in Fig. 1. That route is composed of nine genetically from other known lipases w4,6x. Thus,
steps and chemical resolution with L-lysine was we achieved the decrease of the number of
carried out at the higher molecular weight com- synthetic processes from nine to five and there-
pound 6. Thus, industrial production of dilti- fore the manufacturing cost of diltiazem de-
azem through this resolution process gave a creased to 2r3 compared to the original method
large quantity of waste and the total processes including chemical resolution. Furthermore,
were much fastidious. Although this resolution overproduction of the lipase was performed
since the cost of enzyme production was some-
what high.
In this review, we describe the new method
for the production of optically active intermedi-
ate, glycidic ester, by the newly found lipase
from S. marcescens w3x, cloning of lipase gene
w6x and also its secretion device genes w7x, over-
production of lipase by self-cloning strain w8–
10x, and its application to the industrial scale
with hollow fiber type membrane bioreactor w5x.
Fig. 2. Alignment of homologous regions. The nonapeptide repeat regions of the S. marcescens lipase are aligned with the repeats from the
extracellular secreted proteins, Serratia sp. protease ŽPrtA., E. chrysanthemi protease ŽPrtB., E. coli hemolysin ŽHlyA., P. haemolytica
leukotoxin ŽLktA., B. pertussis cyclolysin ŽCyaA., and R. leguminosarum Ca2q-binding protein ŽNodO.. The numbers refer to the positions
of the amino acid residues in the protein sequences. Identical residues and alterations ŽI–V–M–L–F, D–E, N–Q, R–K and S–T., which are
conserved in more than 60% of the proteins are boxed and nonapeptide repeat units are indicated by arrows.
144 T. Shibatani et al.r Journal of Molecular Catalysis B: Enzymatic 10 (2000) 141–149
pounds by asymmetric hydrolysis. Previously, analogous to hlyBDr tolC and prtDEFEC have
we cloned the lipA gene encoding this enzyme been reported in several bacteria: the aprDEF
from S. marcescens and determined its nu- genes for Pseudomonas aeruginosa alkaline
cleotide sequence w6x. The S. marcescens lipase protease w26x; the cyaBD genes for cyclolysin of
has no conventional N-terminal signal sequence B. pertussis w21x; and the lktBD genes for the P.
and is not subjected to processing at the N haemolytica leukotoxin w27x. Recently, the
terminus. Thus, extracellular secretion of the S. hasDE genes encoding HasD and HasE, which
marcescens lipase is not promoted by the gen- are two inner membrane components of the
eral secretion pathway that require an N-termi- secretion mechanism for the S. marcescens met-
nal signal sequence w16x. S. marcescens, there- alloprotease and the heme-binding protein HasA
fore, possesses a specific secretion system for w28x, have been cloned from S. marcescens
extracellular lipase, which is a signal peptide-in- w29–31x.
dependent pathway w17x. As the characteristics of the genes, lipA and
The 50-kDa metalloprotease encoded by the lipBCD, became clear, we challenged to over-
prtA gene is known as one of the major secre- produce the lipase from S. marcescens for ap-
tory proteins of S. marcescens w17x. No overall plication to industrial production scale.
homology was observed between the S. The wild type strain of S. marcescens ex-
marcescens lipase and metalloprotease amino pressed 30 unitsrml of broth when cultured on
acid sequences except for a homologous region the lipase medium. A S. marcecsens strain,
consisting of multiple repeats of nine amino which has lipA gene in the vector plasmid
acid residues Ž GGXGXDXXX., which is glycine pUC19 and also in the chromosome gene ex-
and aspartic acid rich. This sequence is found in pressed 400 unitsrml of broth when cultured on
the following proteins: metalloproteases; the the lipase medium. A S. marcescens strain,
prtB and prtC gene products of E. chrysan- which has lipA gene and also lipBCD genes on
themi w18x; hemolysin, encoded by the hlyA the same vector cannot grow well on the lipase
gene of E. coli w19x; leukotoxin, encoded by the medium, since too much expression of many
lktA gene of Pasteurella haemolytica w20x; cy- genes of lipBCD affects the growth of the
clolysin, a multifunctional protein with adeny- microorganism. Therefore, we cloned lipA on a
late cyclase activity and hemolytic activity, en- multicopy plasmid, pUC 19 and lipBCD on
coded by the cyaA gene of B. pertussis w21x; another small copy plasmid, pMW 121.
and Ca2q-binding protein, encoded by the nodO Self-transformation of both lipA gene and
gene of Rhizobium leguminosarum w22x. Colicin lipBCD genes resulted in the production of li-
V, the cyaC gene product of E. coli w23x, pase protein at a level of 4200 unitsrml of
possesses a repeated glycine-rich sequence, broth in the culture medium, which is 140-fold
which is not homologous to the GGXGXDXXX compared to the wild type S. marcescens strain.
sequence but shares some characteristics with Details of these results will be reported in an-
this consensus sequence. Although the other paper, which is in preparation.
GGXGXDXXX sequence has been proposed to
be responsible for Ca-binding, the function of
this region is unclear. Most of the proteins 4. Industrial production of optically active
containing the above sequence have been re- diltiazem intermediate using hollow fiber type
ported to be secreted into culture medium by bioreactor
strains with a specialized secretion mechanism
encoded by the hlyBDrtolC genes of E. coli A lipase excreted from S. marcescens Sr41
w23x or the prtDEFEC genes w24x of E. chrysan- 8000 enantioselectively hydrolysed Žq.-MPGM
themi w25x. Genes encoding secretion machinery Ž E s 135, w1x.. The reaction proceeded effi-
146 T. Shibatani et al.r Journal of Molecular Catalysis B: Enzymatic 10 (2000) 141–149
obtained by concentrating the toluene solution. w2x H. Abe, H. Inoue, T. Nagao, Jpn. J. Pharmacol. 108 Ž1988.
716.
From the second to the sixth reaction, 0.2% to 4 w3x H. Matsumae, M. Furui, T. Shibatani, J. Ferment. Bioeng. 75
% of Ž".-MPGM is unreactive after 23 h of Ž1993. 93.
each reaction. The solubility of optically pure w4x H. Matsumae, T. Shibatani, J. Ferment. Bioeng. 77 Ž1994.
152.
MPGM in toluene is nearly equal to half of the w5x H. Matsumae, M. Furui, T. Shibatani, T. Tosa, J. Ferment.
solubility of racemic Ž".-MPGM in toluene. Bioeng. 78 Ž1994. 59.
After the toluene solution containing MPGM is w6x H. Akatsuka, E. Kawai, K. Omori, S. Komatsubara, T.
concentrated from 1.15 to 0.12–015 l, pure Shibatani, T. Tosa, J. Bacteriol. 176 Ž1994. 1949.
w7x H. Akatsuka, E. Kawai, K. Omori, T. Shibatani, J. Bacteriol.
Žy. -MPGM with a high yield of 40–43% and 177 Ž1995. 6381.
optical purity of 99.9% e.e. is obtained by the w8x H. Akatsuka, E. Kawai, K. Omori, S. Komatsubara, T.
crystallization from the concentrated toluene so- Shibatani, J. Ferment. Bioeng. 81 Ž1996. 115.
w9x H. Akatsuka, R. Binet, E. Kawai, C. Wandersman, K. Omori,
lution at 48C. At the seventh and eighth reac- J. Bacteriol. 179 Ž1997. 4754.
tions, the yields of crystalline Žy. -MPGM Ž99.9 w10x E. Kawai, H. Akatsuka, A. Idei, T. Shibatani, K. Omori,
% e.e.. reduced to 38% and 36%, respectively. Mol. Microbiol. 27 Ž1998. 941.
w11x S. Letoffe, J.-M. Chigo, C. Wandersman, J. Bacteriol. 175
The productivity of Sepracor membrane biore- Ž1993. 7321.
actor is about 40 kg Žy. -MPGM per m2 per w12x S. Letoffe, J.-M. Chigo, C. Wandersman, J. Bacteriol. 176
year. Ž1994. 5372.
In conclusion, when the lipase having a high w13x S. Letoffe, P. Delepelaire, C. Wandersman, EMBO J. 9
Ž1990. 1375.
enantioselectivity is immobilized on the mem- w14x R. Binet, C. Wandersman, Mol. Microbiol. 22 Ž1996. 265.
brane reactor suitable for the asymmetric hydro- w15x A. Gilchrist, J.A. Fisher, J. Smit, Can. J. Microbiol. 38
lysis of the key intermediate in the synthesis of Ž1992. 193.
w16x A.P. Pugsley, C. d’Enfert, I. Reyss, M.G. Kornacker, Annu.
diltiazem hydrochloride, the production of Rev. Genet. 24 Ž1990. 67.
Žy. -MPGM is achieved efficiently by simulta- w17x C. Wandersman, Trends Genet. 8 Ž1992. 317.
neous reaction and product separation, and by w18x P. Delepelaire, C. Wandersman, J. Biol. Chem. 265 Ž1990.
17118.
stabilization of the enzyme. w19x T. Felmlee, S. Pellett, R.A. Welch, J. Bacteriol. 163 Ž1985.
On the basis of these results, the pilot-plant 94.
experiments were carried out in collaboration w20x R.Y.C. Lo, C.A. Strathdee, P.E. Shewe, Infect. Immun. 55
with Sepracor, and this technique has been used Ž1987. 1987.
w21x P. Glaser, H. Sakamoto, J. Bellalou, A. Ullmann, A. Danchin,
in the commercial production of diltiazem hy- EMBO J. 9 Ž1990. 349.
drochloride since 1993. w22x A. Economou, W.D.O. Hamilton, J.W.B. Johnston, J.A.
Downie, EMBO J. 9 Ž1990. 349.
w23x L. Gilson, H.K. Mahanty, R. Kolter, EMBO J. 9 Ž1990.
3875.
w24x A. Ludwig, T. Jarchau, R. Benz, W. Goebel, Mol. Gen.
Acknowledgements Genet. 214 Ž1988. 553.
w25x C. Wandersman, P. Delepelaire, Proc. Natl. Acad. Sci. 87
Ž1990. 4776.
The authors thank Dr. I. Chibata and Dr. T. w26x S. Letoffe, P. Delepelaire, C. Wandersman, EMBO J. 9
Tosa, Chairman and Vice-Chairman of Tanabe Ž1990. 1375.
Seiyaku, respectively, for their encouragement w27x A.K. Scheu, A. Economou, G.F. Hong, S. Ghelani, A.W.B.
Johnston, J.A. Downie, Mol. Microbiol. 6 Ž1992. 231.
to our study. w28x J. Guzzo, F. Duong, C. Wandersman, M. Murgier, A. Laz-
dunsk, Mol. Microbiol. 5 Ž1991. 447.
w29x C.A. Strathdee, R.Y.C. Lo, J. Bacteriol. 171 Ž1989. 916.
w30x S. Letoffe, J.M. Ghigo, C. Wandersman, Proc. Natl. Acad.
References Sci. 91 Ž1994. 9876–9880.
w31x S. Letoffe, J.M. Ghigo, C. Wandersman, J. Bacteriol. 176
Ž1994. 5372.
w1x T. Nagao, M. Sato, H. Nakajima, A. Kiyomoto, Jpn. J. w32x R.B. Lieberman, D.F. Dollis, Biotechnol. Bioeng. 17 Ž1975.
Pharmacol. 22 Ž1972. 1. 1401.
T. Shibatani et al.r Journal of Molecular Catalysis B: Enzymatic 10 (2000) 141–149 149
w33x Y. Kimura, A. Tanaka, K. Sonomoto, T. Nihira, S. Fukui, w36x Y.J. Wang, J.Y. Sheu, F.F. Wang, J.F. Shaw, Biotechnol.
Appl. Microbiol. Biotechnol. 17 Ž1983. 107. Bioeng. 31 Ž1988. 628.
w34x J.-F. Shaw, R.-C. Chang, F.F. Wang, Y.J. Wang, Biotechnol. w37x M.M. Hoq, T. Yamane, S. Shimizu, J. Am. Oil Chem. Soc.
Bioeng. 35 Ž1990. 132. 61 Ž1984. 776.
w35x C.O. Ibrahim, H. Saeki, N. Nishio, S. Nagai, Agric. Biol. w38x S.L. Matson, J.A. Quinn, Ann. N. Y. Acad. Sci 469 Ž1986.
Chem. 52 Ž1988. 99. 152.